Brand Vision

From Anti-aging to
Reverse Aging.

2026

Launch of the Re2DN Line

Introducing regenerative creams, regenerative ampoules, mask packs, and acne patches based on our proprietary h-dECM and PDRN technology.

2027

Expansion of the Re2DN Line

Launching innovative medical device products specifically targeted for the treatment of intractable acne, melasma, and erythema.

2028

Re2DN Treatment Centers

Establishment of specialized procedure centers based on the Re2DN product line and our advanced cellular regeneration protocols.

Core
Technology.

01

Supercritical fluid-based ECM molecular size reduction

13,520 Da
3,089 Da

Hydrolyzed dECM showed a reduction in molecular weight from 13,520 Da to 3,089 Da while preserving key ECM components, and fluorescence analysis confirmed its delivery into the dermal layer.

Technology 01
02

Fibroblast activation and ECM remodeling induced by hydrolyzed dECM

Hydrolyzed dECM activated fibroblasts and increased CTGF expression by approximately 2.8-fold, demonstrating a biological response associated with ECM remodeling.

Technology 02
03

VEGF Upregulation observed with hydrolyzed dECM

Increased VEGF expression indicates a biological response associated with angiogenesis and the regenerative microenvironment.

Products Title Background

Our
Products.

Re2DN Dermaplast
Cream

Everyday cell regeneration. Infused with our proprietary h-dECM and PDRN complexes to reverse environmental damage and cellular aging from the comfort of your home.

Re2DN Dermaplast Cream

Re2DN Dermaplast
Lip Balm

An intensive care lip balm formulated with h-dECM and Volufiline, designed to hydrate dry, rough lips while supporting the lip barrier and enhancing volume.

Re2DN Dermaplast Lip Balm

Connect with CellCeutix.

@cellceutix_official

HYM CORP.

Business Registration No: 130-88-03645 Republic of Korea
CEO@hyminternational.com
© 2026 CellCeutix Inc. All rights reserved.